Neurotech Pharmaceuticals, Inc.
Elizabeth Hicks is an experienced professional in the biotechnology and pharmaceutical sectors, currently serving as the Director of National Accounts - Market Access at Neurotech Pharmaceuticals, Inc. since September 2023. Prior to this role, Elizabeth held the position of National Account Director at Y-mAbs Therapeutics, Inc., where responsibilities included managing key National and Regional Accounts in the East and Central US. Elizabeth's robust career includes significant positions at Otsuka America Pharmaceutical, Inc. as Senior Account Executive - Market Access and various roles at Genentech/Roche, including Regional Account Manager and Therapeutic Area Director. Earlier experience includes serving as Account Group Supervisor at Bozell Healthcare Worldwide and Product Manager at Lederle Laboratories/Wyeth-Ayerst, where Elizabeth contributed to portfolio strategy and business planning.
This person is not in the org chart
This person is not in any offices
Neurotech Pharmaceuticals, Inc.
Neurotech Pharmaceuticals, Inc. is a privately held biotech company located in Cumberland, Rhode Island. Neurotech has spent years developing the science, technology, team and manufacturing behind NT-501. As a result of a unique partnership and clear direction, we are focused on bringing a long-term treatment to Macular Telangiectasia (MacTel) patients. Our team is focused on bringing to market this treatment designed to slow the progression of MacTel and the vision impairments it causes in patients who don't have another treatment option. Our goal is to help these patients sustain their quality of life.